Pantoprazole Sodium (Page 10 of 10)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 20 mg (90 Tablets Bottle)

NDC 65862-559-90
Rx only
Pantoprazole Sodium
Delayed-Release Tablets, USP
20 mg*
PHARMACIST: Dispense the Medication Guide
provided separately to each patient. AUROBINDO 90 Tablets

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 20 mg (90 Tablets Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 20 mg (90 Tablets Bottle)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 20 mg Blister Carton (10 x 10 Unit-dose)

NDC 65862-559-10
Rx only
Pantoprazole Sodium
Delayed-Release Tablets, USP
20 mg*
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
AUROBINDO 100 (10 x 10) Unit-dose Tablets

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 20 mg Blister Carton (10 x 10 Unit-dose)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 20 mg Blister Carton (10 x 10 Unit-dose)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 40 mg (90 Tablets Bottle)

NDC 65862-560-90
Rx only
Pantoprazole Sodium
Delayed-Release Tablets, USP
40 mg*
PHARMACIST: Dispense the Medication
Guide provided separately to each patient.
AUROBINDO 90 Tablets

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 40 mg (90 Tablets Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 40 mg Blister Carton (10 x 10 Unit-dose)

NDC 65862-560-10
Rx only

Pantoprazole Sodium
Delayed-Release Tablets, USP
40 mg*
PHARMACIST: Dispense the Medication Guide provided separately to each patient. AUROBINDO 100 (10 x 10) Unit-dose Tablets

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 40 mg Blister Carton (10 x 10 Unit-dose)
(click image for full-size original)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

EPM LABEL
(click image for full-size original)

PANTOPRAZOLE SODIUM pantoprazole sodium tablet, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:67296-1812(NDC:65862-560)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PANTOPRAZOLE SODIUM (PANTOPRAZOLE) PANTOPRAZOLE 40 mg
Inactive Ingredients
Ingredient Name Strength
CALCIUM STEARATE
CROSPOVIDONE (15 MPA.S AT 5%)
FERRIC OXIDE YELLOW
HYDROXYPROPYL CELLULOSE (90000 WAMW)
HYPROMELLOSE 2910 (3 MPA.S)
MANNITOL
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
SODIUM CARBONATE
TRIETHYL CITRATE
AMMONIA
FERROSOFERRIC OXIDE
FERRIC OXIDE RED
ISOPROPYL ALCOHOL
BUTYL ALCOHOL
PROPYLENE GLYCOL
SHELLAC
Product Characteristics
Color yellow Score no score
Shape OVAL (Biconvex) Size 12mm
Flavor Imprint Code I;52
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:67296-1812-7 14 TABLET, DELAYED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA202038 09/28/2012
Labeler — RedPharm Drug (828374897)
Establishment
Name Address ID/FEI Operations
EPM Packaging 079124340 repack (67296-1812)

Revised: 01/2022 RedPharm Drug

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.